Asset Management

Nippon Life India Asset Management delivered a solid third-quarter performance, reporting a sharp rise in net profit on the back of steady asset inflows, higher average assets under management and disciplined cost control. The company benefited from sustained retail participation in mutual funds, resilient equity markets and improving operating leverage. While market volatility remained a factor, diversified product offerings and a growing systematic investment plan base supported earnings stability.

UTI Asset Management Company reported a 20 percent year-on-year decline in net profit for the third quarter, with earnings falling to Rs. 121 crore, reflecting challenging market conditions and pressure on fee income. Volatility in equity markets, coupled with moderation in assets under management growth, weighed on revenue generation during the period. Higher operating expenses and competitive pricing further constrained margins.

Unifi Capital, a Chennai-based asset management firm known for its value-driven investment philosophy, has exited its position in Marksans Pharma Ltd., a mid-cap pharmaceutical company. The move signals a broader rebalancing of the fund’s portfolio as it reassesses sectoral exposure and redeploys capital into new opportunities. While the sale may raise questions about Marksans Pharma’s near-term prospects, market watchers interpret the transaction as a routine investment rotation rather than a bearish outlook.